OV101 (gaboxadol)

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of OV101 in Individuals With Fragile X SyndromeNCT03697161OVIDPhase 2Completed2020-02-03Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.